Duspatalin Retard 200 Mg 30 Capsules

Duspatalin Retard 200 Mg 30 Capsules

Description:

Duspatalin Retard 200 mg 30 Capsules is a prescription antispasmodic medicine containing mebeverine, specifically formulated in a prolonged-release (retard) capsule. It is used to relieve abdominal pain, cramps, and bowel discomfort associated mainly with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. By directly relaxing the smooth muscles of the gastrointestinal tract without affecting normal gut motility, Duspatalin Retard helps reduce painful spasms, bloating, and intestinal cramps while maintaining normal bowel movements.

Indications:

• Management of irritable bowel syndrome (IBS), including abdominal pain, cramping, and discomfort.
• Relief of intestinal spasms and colicky pain of the gastrointestinal tract.
• Functional bowel disorders characterized by spasm and motility disturbances (as assessed by a physician).
• Supportive treatment for symptoms such as bloating, intestinal cramps, and irregular bowel habits associated with IBS.

Active Ingredients / Key Components:

• Mebeverine hydrochloride – 200 mg per prolonged-release capsule.
• Other capsule excipients and shell components: exact excipient list and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the enclosed patient leaflet for full details.

Dosage & Administration / How to Use:

• Duspatalin Retard 200 mg is intended for oral use only.
• Adults and adolescents (as directed by a physician): the usual dose is 1 capsule (200 mg) twice daily, typically one in the morning and one in the evening, or as prescribed by your doctor.
• Swallow the capsule whole with a sufficient amount of water. Do not crush, chew, or open the capsule to preserve the prolonged-release effect.
• It is generally recommended to take the capsules 20 minutes before meals to help prevent meal-related spasms and abdominal pain.
• Duration of use should be determined by your physician based on symptom control. Do not stop treatment abruptly without medical advice if symptoms persist.
• Not recommended for children below 10 years of age. Use in adolescents should be strictly under medical supervision.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

• Provides targeted relief from abdominal pain and cramping associated with irritable bowel syndrome by directly relaxing intestinal smooth muscle.
• Helps reduce bowel spasms and colicky pain without causing significant disturbances to normal gastrointestinal motility.
• Improves comfort in patients with IBS-related symptoms such as bloating, intestinal cramps, and irregular bowel movements.
• Prolonged-release formulation offers sustained symptom control with twice-daily dosing, enhancing convenience and adherence.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity or allergy to mebeverine or any of the excipients in the formulation.
• Not recommended for children below 10 years of age.
• Use with caution in patients with severe hepatic or renal impairment; consult a physician before use.
• If you experience new, severe, or persistent abdominal pain, weight loss, rectal bleeding, fever, or difficulty swallowing, seek medical advice promptly as these may indicate conditions other than IBS.
• Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy should only occur if clearly needed and prescribed by a physician.
• Consult your doctor before use if you are breastfeeding; data on excretion into breast milk are limited.
• Inform your doctor about all other medications you are taking to rule out potential interactions, even though significant interactions with mebeverine are not commonly reported.
• Do not exceed the recommended dose or duration of treatment without medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects are generally mild and may include nausea, mild gastrointestinal disturbances, or headache.
• Allergic reactions such as skin rash, urticaria (hives), itching, or facial and throat swelling (angioedema) may occur in susceptible individuals. If signs of allergy appear, stop taking the medicine and seek immediate medical attention.
• Very rare side effects may include dizziness or mild cardiovascular symptoms; if you feel unwell or notice unusual symptoms, contact your doctor.
• If you experience severe abdominal pain that worsens, persistent vomiting, blood in stool, or any serious or unexpected reaction, stop treatment and seek urgent medical advice.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the outer packaging (refer to leaflet or carton for exact storage temperature if needed).

Specifications:

• Form: Prolonged-release capsules.
• Strength: 200 mg mebeverine hydrochloride per capsule.
• Pack size: 30 capsules per box.
• Intended use: Prescription antispasmodic medicine for irritable bowel syndrome and functional gastrointestinal disorders, for adults and adolescents as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.